1. Content of Botulinum Neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®

   • Jürgen Frevert

   Original Research Article Open access 27 November 2012 Pages: 67 - 73

   

2. Visual Field Protective Effect of Erigeron breviscapus (vant.) Hand. Mazz. Extract on Glaucoma with Controlled Intraocular Pressure

   • Yisheng Zhong
   • Minhong Xiang
   • Youqin Jiang

   Original Research Article Open access 27 November 2012 Pages: 75 - 82

   

3. Metabolism and Disposition of Tribendimidine and Its Metabolites in Healthy Chinese Volunteers

   • Guiyan Yuan
   • Jie Xu
   • Ruichen Guo

   Original Research Article Open access 27 November 2012 Pages: 83 - 90

   

4. Is it Possible to Accurately Determine Content of Botulinum Neurotoxin Type A in Drug Products?

   • Dorothea Sesardic

   Commentary Open access 27 November 2012 Pages: 91 - 92

5. Closed Gateways — Can Neuroprotectants Shield the Retina in Glaucoma?

   • Thirumurthy Velpandian

   Commentary Open access 27 November 2012 Pages: 93 - 96

6. Ipilimumab

   Adis R&D Profile Open access 27 November 2012 Pages: 97 - 110

   

7. Linifanib

   Adis R&D Profile Open access 27 November 2012 Pages: 111 - 122

   

8. Tremelimumab

   Adis R&D Profile Open access 27 November 2012 Pages: 123 - 132